LucenceINSIGHT™
LucenceINSIGHT™ is a multi-cancer early detection test that, from a single standard blood draw, focuses on the cancers most likely to matter for you.
$495 · LucenceINSIGHT™ Core
· May be HSA/FSA eligible.
Test is prescription-only and must be ordered by a healthcare provider.
Request the test via an independent telemedicine healthcare provider.
What LucenceINSIGHT™ Core screens for
From one blood draw, LucenceINSIGHT™ Core screens six essential cancers.
-
Liver
-
Pancreatic
-
Lung
-
Colorectal
-
Breast
-
Thyroid
Together these account for more than half of US cancer mortality. [1]
Start with LucenceINSIGHT™ Core. Make it yours.
Your family history is unique, so your screening should be too. When you request your test, you can refine it based on your family history:
-
add up to 3 additional cancers most relevant to you (LucenceINSIGHT™ Me) OR
-
choose the broadest panel across 12 cancers (LucenceINSIGHT™ 12).
6
cancers
6 essential cancers. Your starting point.
LucenceINSIGHT™ Core
9
cancers
LucenceINSIGHT™ Core plus your chosen 3 cancers.
LucenceINSIGHT™ Me
12
cancers
Comprehensive 12-cancer screening, tailored by gender.
LucenceINSIGHT™ 12
LucenceINSIGHT Core
Essential screening for signals associated with 6 cancer types,
accounting for >50% of US cancer mortality. [1]
.png)
_ordering.png)
Ordering Workflow
1. Request online
Submit a request for the test online.
2. Physician review
A licensed physician reviews your request and, if appropriate, places the order (prescription required).
3. Kit delivery
We’ll ship the test kit to you, along with a link to schedule your mobile blood draw.
4. At-home blood collection
A phlebotomist will collect your blood sample in the comfort of your home.
5. Results & next steps
We’ll process your sample, and your physician will reach out to discuss your results and any next steps, if needed.
_pricing.png)
Pricing
$495
LucenceINSIGHT™ Core list price
-
Fully refundable if deemed ineligible by a physician.
-
May be HSA/FSA eligible.
-
Pay in up to 20 installments via Klarna, subject to the terms of their payment plans.
-
Higher-coverage panels (LucenceINSIGHT™ Me, LucenceINSIGHT™ 12) available at higher list prices.
References:
-
Cancer Stat Facts. NIH NCI SEER. Accessed July 14, 2026. https://seer.cancer.gov/statfacts/. Cancer Mortality Coverage represents the percentage or range of US cancer deaths accounted for by the specific test panel: LucenceINSIGHT™ Core (6 cancer types), LucenceINSIGHT™ Me (6 fixed cancer types plus 3 selected; percentage varies by selection), or LucenceINSIGHT™ 12 (12 cancer types). Totals exclude cancer deaths from unspecified sites or other non-listed malignancies and are calculated as upper limits of US cancer mortality extracted from GLOBOCAN 2024 data. Cancer sites were matched to GLOBOCAN categories using the closest available sex-specific mortality data. All percentages derived from GLOBOCAN data are conservative estimates.